Consumer Perceptions of Health Claims in Vape Shops

消费者对电子烟商店健康声明的看法

基本信息

批准号：
9440627
负责人：
Kimberly G. Wagoner
金额：
$ 11.63万
依托单位：
WAKE FOREST UNIVERSITY HEALTH SCIENCES
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-09-21 至 2019-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9440627
关键词：
Address Adult Advertisements Advertising Age Categories Collection Confusion Data Data Collection Decision Making Devices Drug Evaluation Electronic Nicotine Delivery Systems Environment Evaluation Evaluation Research Family Smoking Prevention and Tobacco Control Act Funding Future Grant Health Health system Image Imaging technology Knowledge Label Laws Literature Marketing Measures Methodology Methods North Carolina Online Systems Participant Perception Pilot Projects Printed Media Process Product Labeling Public Health Research Research Personnel Research Priority Risk Safety Sampling Series Surveys Television Testing Therapeutic Time Tobacco United States Food and Drug Administration United States National Institutes of Health Virginia Weight maintenance regimen Work authority falls smoking cessation tobacco advertising tobacco regulatory science vaping

项目摘要

PROJECT SUMMARY/ABSTRACT In May 2016, the Food and Drug Administration (FDA) issued a Final Rule, bringing electronic nicotine delivery systems (ENDS) and other products that meet a statutory definition of a tobacco product under its authority. Federal law explicitly prohibits five categories of labelling and advertising for tobacco products including: (1) false and/or misleading; (2) FDA-approved or FDA-endorsed, without FDA approval; and (3) modified risk tobacco product, without FDA approval. Additionally, ENDS cannot be marketed as a product for (4) smoking cessation or for (5) other therapeutic purposes, without prior approval from the FDA's Center for Drug Evaluation and Research (CDER). Although these types of ENDS claims have been documented online and in print media, it can be difficult to identify prohibited claims as they are often implicit. The FDA has been tasked with considering consumer perceptions of such claims when determining if they are prohibited; however, there is a significant gap in the literature regarding consumer perceptions of health claims. Additionally, no research has been conducted on advertising claims made in vape shops, which are the fastest growing segment of ENDS retailers. This study will build upon a pilot grant that developed the methodology to photographically document ENDS claims in vape shops using wearable imaging technology. In the proposed study, we will use this methodology to conduct an additional wave of data collection to document claims in vape shops. The claims from both the pilot and the new wave of data collection will be combined to create a comprehensive list of unsubstantiated claims for use in a survey, which will investigate consumer perceptions of them. It will be the first of its kind to assess how consumers interpret these real-world ENDS health claims made by retailers. At the conclusion of this study, we will have developed robust methodologies for capturing claims in the ENDS retail environment; expanded the knowledge of the types of ENDS claims being made to consumers; and developed measures for assessing consumer perceptions of those claims, all of which will aid the FDA in making determinations of whether such claims fall into one of their prohibited categories. This focused project, led by a New Investigator working with a nationally recognized team of collaborators, will lay the groundwork for future, larger studies that will increase the body of evidence regarding ENDS and directly inform the process in which the FDA identifies and classifies prohibited advertising claims.

项目概要/摘要 2016 年 5 月，美国食品药品监督管理局 (FDA) 发布了最终规则，将电子化尼古丁输送系统 (ENDS) 和其他符合法定定义的产品其管辖下的烟草产品。联邦法律明确禁止五类标签烟草产品广告包括： (1) 虚假和/或误导性的； (2) FDA 批准或 FDA认可，未经FDA批准； (3) 改良风险烟草产品，未经 FDA 批准赞同。此外，ENDS 不能作为用于 (4) 戒烟或用于戒烟的产品进行销售。 (5) 未经 FDA 药物中心事先批准的其他治疗目的评估与研究（CDER）。尽管这些类型的 ENDS 声明已被在网上和印刷媒体上都有记录，因此很难识别被禁止的声明，因为它们是常常是隐含的。 FDA 的任务是考虑消费者对此类声明的看法在确定它们是否被禁止时；然而，文献中存在显着差距关于消费者对健康声明的看法。此外，还没有进行任何研究关于电子烟商店的广告宣传，电子烟商店是 ENDS 增长最快的部分零售商。这项研究将建立在一项试点拨款的基础上，该拨款开发了一种方法使用可穿戴成像技术以照片方式记录电子烟商店中的 ENDS 声明。在在拟议的研究中，我们将使用这种方法来进行额外的数据波收集电子烟商店的索赔文件。来自试点和新浪潮的说法收集的数据将被合并起来，以创建一份未经证实的索赔的综合清单用于调查，调查消费者对它们的看法。这将是同类中的第一个评估消费者如何解读零售商在现实世界中提出的 ENDS 健康声明。在这项研究的结论是，我们将开发出可靠的方法来捕获索赔在 ENDS 零售环境中；扩展了对 ENDS 声明类型的了解为消费者制造；并制定了评估消费者对这些产品的看法的措施声明，所有这些都将帮助 FDA 确定此类声明是否属于他们的禁止类别之一。这个重点项目由一名新研究员领导，并与国家认可的合作者团队将为未来更大规模的研究奠定基础将增加有关 ENDS 的证据，并直接告知该过程 FDA 对禁止的广告声明进行识别和分类。